SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs > Peregrine Pharmaceuticals (PPHM)

To quote Mark Twain, "The rumors of my

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stoneroad Member Profile
Member Level 
Followed By 35
Posts 3,388
Boards Moderated 0
Alias Born 02/12/09
160x600 placeholder
Advertisement
3 Key Takeaways From Peregrine Pharmaceuticals' Fourth-Quarter Results "The Motley Fool" - 7/15/2015 5:10:02 PM
Peregrine Pharmaceuticals Q4 Earnings Preview "The Motley Fool" - 7/10/2015 4:02:02 PM
Small Cap Stocks to Watch in Biotech "The Motley Fool" - 6/30/2015 12:02:03 PM
Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports "InvestorsHub NewsWire" - 6/15/2015 7:00:00 AM
1 Drug Will Make or Break These 3 Biotech Stocks "The Motley Fool" - 6/13/2015 7:18:02 AM
Special Profile & Four Companies Where Investors are Anticipating Success "InvestorsHub NewsWire" - 6/3/2015 7:00:00 AM
Peregrine Pharmaceuticals' Immuno-Oncology Agent Bavituximab to be Highlighted in Three Presentations at 2015 ASCO Annual Mee... "GlobeNewswire Inc." - 5/13/2015 5:00:00 PM
*Special Analyst Alert* and 4 Companies that are Worth a Look "InvestorsHub NewsWire" - 5/13/2015 7:00:00 AM
Preclinical Data Presented at AACR Demonstrate Synergistic Anti-Tumor Effects of Peregrine Pharmaceuticals' Phosphatidylserin... "GlobeNewswire Inc." - 4/21/2015 8:00:00 AM
Peregrine Pharmaceuticals Given a $5.00 Price Target at Roth Capital (PPHM) "Analyst Ratings Network" - 4/20/2015 3:24:37 PM
Data Presented at AACR Demonstrate Peregrine Pharmaceuticals' Bavituximab Induces Immune Activation in PD-L1 Negative NSCLC T... "GlobeNewswire Inc." - 4/20/2015 8:00:00 AM
Peregrine Pharmaceuticals Announces Three Abstracts Accepted for Presentation at AACR 2015 Annual Meeting "GlobeNewswire Inc." - 4/14/2015 8:00:00 AM
5 Promising Biotech Stocks Under $10 "The Motley Fool" - 4/3/2015 8:04:02 AM
Peregrine Pharmaceuticals Announces Promising Bavituximab Phase I Data Published in the Peer-Reviewed Journal Cancer Medicine... "GlobeNewswire Inc." - 3/31/2015 12:45:22 PM
Peregrine Pharmaceuticals Reports Third Quarter Fiscal Year 2015 Financial Results and Recent Developments "GlobeNewswire Inc." - 3/12/2015 4:00:00 PM
Independent Research Initiates Analyst Coverage on Inventergy Global, Inc. (NASDAQ: INVT) with $1.20 Price Target "InvestorsHub NewsWire" - 3/12/2015 8:00:00 AM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 3/10/2015 4:00:00 PM
Peregrine Pharmaceuticals to Report Third Quarter Fiscal 2015 Financial Results After Market on March 12, 2015 "GlobeNewswire Inc." - 3/5/2015 4:00:00 PM
Peregrine Pharmaceuticals to Present at the 27th Annual ROTH Conference "GlobeNewswire Inc." - 3/2/2015 4:00:00 PM
NEW CONCEPT LAUNCHES TODAY FOR MICRO-CAP STOCK TRADERS. RECEIVE PAID PRE-PROMO STOCK ALERTS FOR FREE. "InvestorsHub NewsWire" - 2/9/2015 7:00:00 AM
ALTITRADE PARTNERS™ SAYS A KEY-REVERSAL DAY COULD HAPPEN THIS WEEK "InvestorsHub NewsWire" - 10/14/2014 6:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist